Remond J.A. Fijneman, PhD, is Associate Staff Scientist / Principal Investigator at the Netherlands Cancer Institute in Amsterdam, with special interest in colorectal cancer translational research. He obtained his university degree in chemistry at the RU Leiden (1991), completed his PhD studies in cancer genetics at the Netherlands Cancer Institute (1997), and performed his postdoc studies at the Brigham and Women’s Hospital / Harvard Medical School (Boston, USA) as a fellow from the Dutch Cancer Society. In 2000 he went to the VU University Medical Center where he worked in the departments of Molecular Cell Biology and Immunology; Medical Oncology; and Pathology. In 2004 he joined the Tumor Profiling Unit (head: prof.dr. Gerrit A. Meijer) where he became Associate Professor. The group of prof.dr. Meijer moved to the Netherlands Cancer Institute (2015) where in a strong team effort dr. Remond Fijneman, together with dr. Beatriz Carvalho, is (co)responsible for multiple colorectal cancer and research infrastructure projects.
Research activities focus on the molecular mechanisms underlying tumor progression through molecular characterization at DNA, RNA, and protein level. Emphasis is put on identification and validation of diagnostic, prognostic, and predictive biomarkers for translation into clinical applications, research that is often carried out in public private partnerships (a.o. CTMM DeCoDe, SU2C MEDOCC dreamteam). In addition, significant effort is put in improvement of the (inter)national translational research IT infrastructure (a.o. CTMM TraIT) to support and enable molecular research in the context of translational research projects.
SESSION CHAIR – Session A1 – Scientific Applications of tranSMART Platform